A team of researchers studying genetic data to identify hormone responses in a population of Mexican Americans with prediabetes, Type 2 diabetes, and obesity recently received a $3.5 million grant to fund a five-year study set to begin in late 2021.
Male infertility is on the rise, with significant declines in sperm quantity and quality occurring across the human population worldwide in the past two decades. The reason for this is poorly understood, but scientists suspect spermatogenesis – the process by which sperm develops – is a crucial piece in this puzzle.
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH’s Community Engagement Alliance (CEAL) Against COVID-19 Disparities. The Philly CEAL team was awarded $1.4 million from the NIH with additional support from Penn Nursing and The University of Pennsylvania, bringing the total for the alliance to $1.53 million.
A Florida State University researcher will lead a study into how bacteria can be used to remove carcinogens from groundwater thanks to a $1.4 million grant from the National Institute of Environmental Health Sciences.
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.
New Brunswick, NJ — Rutgers researchers have been awarded $1.6 million from the National Institutes of Health in support of the creation of a national collaborative network seeking to identify risk and protective factors that may allow clinicians or public health…
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, has been re-funded for the next seven years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and collaborating NIH Institutes.
the National Institutes of Health has renewed a Center of Biomedical Research Excellence (COBRE) grant at the University of Delaware. The COBRE research team is focused on discovery of new molecules that can be used to study and treat diseases such as breast cancer, renal cancer, Crohn’s disease, tuberculosis and Legionnaires disease.
The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute and the University of Texas Health Science Center at San Antonio received a $1.3 million collaborative grant to continue the San Antonio Marmoset Aging Program (SA MAP) and further define the hallmarks of aging in a nonhuman primate (monkey) model. Developing the marmoset model will allow for eventual testing of interventions in additional model systems that could slow or change age-related decline in humans.
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.
Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award.
Oni Basu, PhD, an assistant professor of genetic medicine at the University of Chicago, has received the prestigious National Institutes of Health (NIH) Director’s New Innovator Award. These awards are given to exceptionally creative scientists proposing high-risk, high-impact research at all career stages.
UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies.
Luis M. Tuesta, Ph.D., assistant professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine, has been awarded the Avenir Award from the National Institute on Drug Abuse, part of the National Institutes of Health, to study the epigenetic mechanisms of microglial activation and their role in shaping the behavioral course of opioid use disorder.
Using a multimillion-dollar grant from the NIH, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country.
UCAL researchers are developing a nanotechnology-enabled cancer diagnostic solution that will help detect early stage liver cancer for people who are at risk of developing the disease.
Yale Cancer Center researchers were awarded a $11 million grant renewal from the National institutes of Health to fund the Yale Specialized Program of Research Excellence (SPORE) in Lung Cancer.
Satya Dandekar, professor of microbiology and chairperson of the Department of Medical Microbiology and Immunology at UC Davis, honored by Prestigious NIH MERIT award for her illustrious journey in HIV research.
The newly awarded $8.6 million funding keeps Coriell in place as the trusted steward of this collection and includes the addition of new innovative products to expand the collection. The NIA Aging Cell Repository was established at Coriell in 1974 and Coriell has continuously managed this unique resource ever since.
The quest to conquer cancer is motivating a team of researchers at the University of Oklahoma to develop a 3D scanner capable of guiding the radiation treatment, dispensing just the right amount of radiation to just the precise location, making real-time adjustments as treatment is delivered.
The five-year award will support the NINDS Human Genetics Resource Center, a collection of biological samples and corresponding demographic, clinical, and genetic data made available to qualified researchers around the world. This repository includes samples from subjects with various diseases – such as cerebrovascular disease, dystonia, epilepsy, motor neuron disease, parkinsonism, and Tourette Syndrome.
New “big omics” supercomputer will speed up solutions; insights will lead to advances in a wide range of complex diseases
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $3.58 million grant to Sanford Burnham Prebys scientist Anthony Pinkerton, Ph.D., to advance a potential treatment for opioid-use disorders, called SBI-553.
Notre Dame’s Cody Smith has been granted a highly competitive National Institutes of Health Director’s New Innovator Award that will allow him to perform bold research that has the potential to impact a broad area of science.